Showing results (51-60 of 121) with videos related to

Sort By:
Pageof 13
Methods in Molecular Biology (Clifton, N.J.)|April 20, 2010
Evaluation of efflux activity of bacteria by a semi-automated fluorometric systemMiguel Viveiros, Liliana Rodrigues, Marta Martins, et al.
Expert Review of Anti-Infective Therapy|April 10, 2010
Molecular tools for rapid identification and novel effective therapy against MDRTB/XDRTB infectionsMiguel Viveiros, Marta Martins, Isabel Couto, et al.
Expert Review of Anti-Infective Therapy|October 31, 2012
Inhibitors of mycobacterial efflux pumps as potential boosters for anti-tubercular drugsMiguel Viveiros, Marta Martins, Liliana Rodrigues, et al.
In Vivo (Athens, Greece)|May 27, 2006
Synergistic interaction between proton pump inhibitors and resistance modifiers: promoting effects of antibiotics and plasmid curingKristina Wolfart, Gabriella Spengler, Masami Kawase, et al.
International Journal of Antimicrobial Agents|March 2, 2010
Thioridazine cures extensively drug-resistant tuberculosis (XDR-TB) and the need for global trials is now!Leonard Amaral, Martin J Boeree, Stephen H Gillespie, et al.
International Journal of Antimicrobial Agents|January 22, 2009
SILA 421, an inhibitor of efflux pumps of cancer cells, enhances the killing of intracellular extensively drug-resistant tuberculosis (XDR-TB)Marta Martins, Miguel Viveiros, Jorge Ramos, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 25, 2016
Fluorimetric Methods for Analysis of Permeability, Drug Transport Kinetics, and Inhibition of the ABCB1 Membrane TransporterAna Armada, Célia Martins, Gabriella Spengler, et al.
International Journal of Antimicrobial Agents|September 11, 2009
The role of efflux pumps in macrolide resistance in Mycobacterium avium complexLiliana Rodrigues, Daniela Sampaio, Isabel Couto, et al.
Anticancer Research|July 4, 2012
Inhibitors of bacterial efflux pumps that also inhibit efflux pumps of cancer cellsLeonard Amaral, Gabriella Spengler, Ana Martins, et al.
Pageof 13